Biweekly docetaxel and vinorelbine with granulocyte colony-stimulating factor support for patients with anthracycline-resistant metastatic breast cancer.

Gómez-Bernal, Amalia

Biweekly docetaxel and vinorelbine with granulocyte colony-stimulating factor support for patients with anthracycline-resistant metastatic breast cancer. [electronic resource] - Anti-cancer drugs Jan 2005 - 77-82 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article

0959-4973

10.1097/00001813-200501000-00011 doi


Adult
Aged
Anthracyclines--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Breast Neoplasms--drug therapy
Carcinoma, Ductal, Breast--drug therapy
Carcinoma, Lobular--drug therapy
Disease Progression
Docetaxel
Drug Administration Schedule
Female
Granulocyte Colony-Stimulating Factor--administration & dosage
Hematologic Agents--administration & dosage
Humans
Middle Aged
Neoplasm Staging
Neutropenia--chemically induced
Survival Analysis
Taxoids--administration & dosage
Time Factors
Treatment Failure
Treatment Outcome
Vinblastine--administration & dosage
Vinorelbine